BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Medtronic
Farmers Insurance
Healthtrust
Express Scripts
Argus Health
Federal Trade Commission
McKinsey
Daiichi Sankyo
McKesson

Generated: January 16, 2018

DrugPatentWatch Database Preview

TESLAC Drug Profile

« Back to Dashboard

Which patents cover Teslac, and when can generic versions of Teslac launch?

Teslac is a drug marketed by Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in TESLAC is testolactone. There are two drug master file entries for this compound. Additional details are available on the testolactone profile page.
Drug patent expirations by year for TESLAC
Medical Subject Heading (MeSH) Categories for TESLAC

US Patents and Regulatory Information for TESLAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb TESLAC testolactone INJECTABLE;INJECTION 016119-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb TESLAC testolactone TABLET;ORAL 016118-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bristol Myers Squibb TESLAC testolactone TABLET;ORAL 016118-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Covington
Moodys
Cantor Fitzgerald
US Department of Justice
Cerilliant
Baxter
Accenture
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot